Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP

• Xuemei Huang ,

  * E-mail: Xuemei@psu.edu

  Affiliation Departments of Neurology, Neurosurgery, Pharmacology, Radiology, and Kinesiology, Pennsylvania State University-Milton Hershey Medical Center, Hershey, Pennsylvania, United States of America

  ⨯
• Peggy Auinger,

  Affiliation Department of Neurology, Center for Human Experimental Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Shirley Eberly,

  Affiliation Department of Biostatistics, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• David Oakes,

  Affiliation Department of Biostatistics, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Michael Schwarzschild,

  Affiliation Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Alberto Ascherio,

  Affiliation Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Richard Mailman,

  Affiliation Departments of Neurology and Pharmacology, Pennsylvania State University-Milton Hershey Medical Center, Hershey, Pennsylvania, United States of America

  ⨯
• Honglei Chen,

  Affiliation Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America

  ⨯
• for the Parkinson Study Group DATATOP Investigators

  ¶The full list of DATATOP investigators/coordinators can be found in the file Supporting Information S1.

  ⨯